Skip to Main Content
Contribute Try STAT+ Today

For radiologists working today, the specter of artificial intelligence is inescapable.

In the past year, venture capitalists have continued to invest significantly in startups developing AI for medical image analysis and support, with some groups projecting a $20 billion market by 2031. But despite the proliferation of research and investment, AI products are still a hard sell for many radiology practices — even those at academic centers leading clinical research into deep learning. The tools are still in the middle of the hype cycle for any new technology: Inflated expectations are giving way to skepticism and barriers to adoption.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment